Neuroligins are postsynaptic cell-adhesion molecules that interact with presynaptic neurexins. Rare mutations in neuroligins and neurexins predispose to autism, including a neuroligin-3 amino acid substitution (R451C) and a neuroligin-3 deletion. Previous analyses showed that neuroligin-3 R451C-knockin mice exhibit robust synaptic phenotypes but failed to uncover major changes in neuroligin-3 knockout mice, questioning the notion that a common synaptic mechanism mediates autism pathogenesis in patients with these mutations. Here, we used paired recordings in mice carrying these mutations to measure synaptic transmission at GABAergic synapses formed by hippocampal parvalbumin-and cholecystokinin-expressing basket cells onto pyramidal neurons. We demonstrate that in addition to unique gain-of-function effects produced by the neuroligin-3 R451C-knockin but not the neuroligin-3 knockout mutation, both mutations dramatically impaired tonic but not phasic endocannabinoid signaling. Our data thus suggest that neuroligin-3 is specifically required for tonic endocannabinoid signaling, raising the possibility that alterations in endocannabinoid signaling may contribute to autism pathophysiology.
INTRODUCTION
Neuroligins are postsynaptic cell-adhesion molecules that are expressed in four principal isoforms (neuroligin-1 to -4, abbreviated as NL1 to NL4), and that act as ligands for presynaptic neurexins (Ichtchenko et al., 1995; 1996) . NL1 is found in excitatory synapses (Song et al., 1999) , NL2 in inhibitory synapses (Varoqueaux et al., 2004; Graf et al., 2004) , NL3 in both (Budreck and Scheiffele, 2007) , and NL4 in glycinergic synapses (Hoon et al., 2011) . In humans, more than 30 neuroligin gene mutations have been associated with autism, including a NL3 point mutation (the R451C substitution; Jamain et al., 2003) and a NL3 deletion (Sanders et al., 2011) .
Experiments with knockout (KO) mice revealed that neuroligins are essential for synaptic transmission and suggest that neuroligins organize synapses and determine synapse properties (Varoqueaux et al., 2006) . Specifically, triple KO mice lacking NL1, NL2, and NL3 die at birth because their synapsesalthough morphologically normal-exhibit severe impairments in synaptic transmission (Varoqueaux et al., 2006) . Moreover, single KO mice lacking either NL1 or NL2 exhibit major deficits in excitatory or inhibitory synaptic transmission, respectively (Chubykin et al., 2007; Gibson et al., 2009; Poulopoulos et al., 2009) . NL3 KO mice display changes in spontaneous ''mini'' synaptic events in the hippocampus (Tabuchi et al., 2007; Etherton et al., 2011a) and in mGluR5 signaling in the cerebellum (Baudouin et al., 2012) . Together, these findings are consistent with the notion that neuroligins specify synaptic properties instead of functioning as general ''glues'' for synapses (Varoqueaux et al., 2006) . These conclusions are additionally supported by characterization of another NL3 mutation, the R704C substitution (Etherton et al., 2011b) . The R704C substitution corresponds to an autism-associated mutation in NL4 that, when introduced into NL3, selectively altered postsynaptic AMPAtype glutamate receptor levels, confirming that neuroligins contribute to shaping synapse properties.
In contrast to NL3 KO mice, NL3 knockin (KI) mice carrying the R451C substitution (that mimics a human autism mutation similar to the NL3 KO) displayed robust synaptic phenotypes, which differed between the somatosensory cortex and hippocampus and were absent from NL3 KO mice (Tabuchi et al., 2007; Etherton et al., 2011a; see also Sü dhof, 2008) . Although different behavioral phenotypes were reported for two independently generated R451C KI mouse lines (Tabuchi et al., 2007; Chadman et al., 2008) , both mouse lines exhibited the same region-specific changes in synaptic function (Etherton et al., 2011a) . These changes in NL3 R451C-mutant mice were largely due to gain-of-function mechanisms because the NL3 KO synapses did not exhibit the same changes, even though the R451C substitution destabilizes NL3 (De Jaco et al., 2010) and caused a loss of more than 90% of NL3 protein in vivo (Tabuchi et al., 2007) . Because both the inactivation and the R451C substitution of NL3 are implicated in autism, it seems likely that the gain-of-function changes, as opposed to the loss-offunction changes, may not be relevant for understanding autism. However, to date, no synaptic phenotype was detected that is shared by the two known autism-associated NL3 mutations, raising the question of how these mutations may actually induce autism.
To gain insight into how different NL3 mutations might contribute to autism pathogenesis, we here followed up on the observation that the NL3 KO increases inhibitory and decreases excitatory spontaneous mini events in the hippocampus (Etherton et al., 2011a) . Since the NL3 KO did not alter evoked excitatory synaptic strength in the hippocampus, we hypothesized that the NL3 KO may cause a specific change in a subset of inhibitory synapses. The hippocampus contains multiple, at least 21, different types of inhibitory neurons that exhibit specific circuit properties (Klausberger and Somogyi, 2008) . Thus, when examining inhibitory synaptic transmission, it is advantageous to investigate specific synapses formed by identified types of inhibitory neurons. To this end, we performed paired recordings that monitor synapses formed by two different defined types of inhibitory basket cells onto the soma and proximal dendrites of pyramidal neurons. One type of basket cell coexpresses presynaptic cannabinoid type-1 (CB1) receptors and the neuropeptide cholecystokinin (CCK; ''CCK basket cells''), whereas the other type expresses parvalbumin (PV; ''PV basket cells''; Freund, 2003; Freund et al., 2003; Bartos et al., 2007; Klausberger and Somogyi, 2008) . The two types of basket cells participate in parallel inhibitory systems that play distinct but complementary roles in network oscillations (Bartos et al., 2007; Klausberger et al., 2005) and have been implicated in neurological and mood disorders (Freund and Katona, 2007; Lisman et al., 2008) . In these paired recordings, we sought to identify specific loss-of-function effects that are shared by both the NL3 KO and the R451C KI mutation since both are associated with autism, prompting us to analyze both mutations in parallel.
Our data show that NL3 R451C KI and NL3 KO neurons exhibit distinct phenotypes at synapses formed by PV basket cells, similar to previous observations in other synapses (Tabuchi et al., 2007; Etherton et al., 2011a) . Surprisingly, however, we find that at synapses formed by CCK basket cells, the two mutations produced the same phenotype that consisted of a loss of the tonic CB1 receptor-dependent suppression of GABA release that is observed at these synapses (Losonczy et al., 2004; Hentges et al., 2005; Neu et al., 2007; Ali and Todorova, 2010; Kim and Alger, 2010) . This observation identifies NL3 as the first molecule that is selectively essential for tonic endocannabinoid signaling, an enigmatic component of overall endocannabinoid signaling (Alger, 2012) . Given the common genetic association of the R451C substitution and NL3 deletion with autism, our data thus suggest that disrupted endocannabinoid signaling may contribute to autism pathophysiology, a tantalizing idea given the great interest in developing therapeutic approaches that modify endocannabinoid signaling in the brain.
RESULTS

R451C KI Impairs GABAergic Synaptic Transmission at PV Basket Cell Synapses
We performed paired whole-cell recordings between presynaptic basket cells and postsynaptic CA1 pyramidal neurons in acute slices from littermate wild-type and R451C KI mice (Tabuchi et al., 2007) . In these recordings, we determined the characteristics of synaptic transmission by measuring unitary inhibitory post-synaptic currents (IPSCs) evoked by basket cell action potentials (APs) (see Experimental Procedures for details).
We found that the R451C KI severely impaired synaptic transmission at synapses formed by PV basket cells onto pyramidal neurons ( Figures 1A and 1B) . The amplitude of IPSCs was decreased by $70% (failures included), and the success rate with which an AP elicited an IPSC was lowered by $20%. This phenotype was observed independent of whether APs were induced at 1 Hz, 2 Hz, or 10 Hz. In addition, we observed a statistically insignificant decrease in IPSC half-widths ( Figure 1C ; WT: 5 ± 0.3 ms, R451C: 4.3 ± 0.2 ms). The impairment of IPSCs in R451C KI neurons was independent of postsynaptic membrane potential (analyzed from À80 to +60 mV; Figure 1E and see Figure S1 available online) , and the R451C KI did not affect the reversal potential of PV basket cell-evoked IPSCs (WT: À18.6 ± 1.9 mV, R451C: À19.4 ± 2.1 mV). Moreover, we observed no change in the amplitude of the minimal unitary IPSC that could be evoked by a presynaptic AP, suggesting that single synaptic events elicited similar postsynaptic responses ( Figure 1D ; WT: 22.5 ± 3.5 pA, R451C: 16.4 ± 0.8 pA). We also found no change in the number of trials needed to identify synaptically connected pairs of PV basket cell/pyramidal neurons, indicating that the number of pyramidal neurons innervated by individual PV basket cells was not altered ( Figure 1F ; WT: 1.8 ± 0.3, R451C: 1.8 ± 0.2 trials per presynaptic basket cell). Finally, we did not detect major morphological changes in the axonal or dendritic arbor of PV basket cells in R451C KI mice ( Figure 1G ).
Together, these data show that the R451C KI produces a large impairment in synaptic transmission at synapses formed by PV basket cells onto pyramidal neurons. The lack of a change in the voltage-dependence of IPSCs, the reversal potential, and the minimal unitary IPSC size suggest that the R451C KI did not alter the number of postsynaptic GABA receptors or disrupt postsynaptic chloride homeostasis, while the lack of change in the IPSC kinetics suggests that the subunit composition of GABA-receptors or the reuptake kinetics of released GABA were not altered significantly. The decrease in the success rate of eliciting an IPSC from PV basket cells suggests that the R451C KI impaired synaptic transmission by a presynaptic mechanism, despite the presumed postsynaptic localization of NL3. Notably, this is the first phenotype of the R451C mutation that entails a decrease in synaptic strength, not an increase as previously observed for global inhibitory synaptic transmission in the somatosensory cortex (Tabuchi et al., 2007) and for both AMPA-and NMDA-receptor-mediated excitatory synaptic transmission in the hippocampus (Etherton et al., 2011a) .
The R451C KI Enhances GABAergic Synaptic Transmission at CCK Basket Cell Synapses We next analyzed the properties of transmission at pyramidal synapses formed by CCK basket cells. Surprisingly, here the R451C KI caused an $100% increase in the IPSC amplitudes and an $15% increase in the IPSC success rate during 1 Hz stimulation and a slightly smaller change during 2 and 10 Hz stimulation (Figures 2A and 2B ). The increase in success rate suggests an increase in the presynaptic GABA release probability, which is also a plausible explanation for the increase in IPSC amplitudes. This hypothesis was further supported by the absence of detectable changes in the IPSC half-width, indicating that the GABA-receptor subunit composition or uptake mechanisms were unaltered ( Figure 2C ; WT: 6.3 ± 0.4 ms, R451C: 5.4 ± 0.3 ms). Furthermore, the amplitude of minimal unitary IPSCs ( Figure 2D ; WT: 23.4 ± 4.3 pA, R451C: 29.6 ± 4 pA) and the rate of finding connected pairs ( Figure 2E ; WT: 2.6 ± 0.7, R451C: 2.2 ± 0.3) were similar in wild-type and R451C mutant slices, as was the morphology of their CCK basket cells ( Figure 2F ). The phenotype of the R451C mutation in the CCK cell synapses again was more consistent with a presynaptic change (such as increased release probability) than a structural alteration (e.g., increase in synapse density) or postsynaptic effect. Thus, the R451C KI produces opposite changes at two different perisomatic inhibitory synapses, and in both cases the changes appear to involve an ultimately presynaptic mechanism, even though NL3 is a postsynaptic molecule.
A Synaptic Phenotype of NL3 KO Mice
To test whether the R451C KI phenotypes represent gain-or loss-of-function effects, we next performed paired recordings in acute slices from NL3 KO mice, again using littermate wildtype mice as controls. When we analyzed the properties of transmission between PV basket cells and pyramidal neurons, we failed to detect a phenotype. Specifically, the amplitude and success rate of IPSCs were unchanged ( Figures 3A and 3B ), as were the half-width of the IPSCs ( Figure 3C ; WT: 4.7 ± 0.2 ms, NL3 KO: 5.5 ± 0.4 ms), the size of unitary minimal IPSCs ( Figure 3D ; WT: 17.6 ± 1.6 pA, NL3 KO: 16.5 ± 1.1 pA) and the rate of finding connected pairs ( Figure 3E ; WT: 2.2 ± 0.3, NL3 KO: 2.5 ± 0.6). These results suggest that the loss of synaptic transmission at this synapse in R451C mutant mice represents an active suppression of synaptic transmission by a gain-of-function activity of R451C mutant NL3.
We then examined the effect of the NL3 KO on synaptic transmission mediated by inhibitory synapses that were formed by CCK-containing terminals on pyramidal neurons (Figure 4 ). Surprisingly, here the NL3 KO phenocopied the R451C KI. Specifically, the NL3 KO caused a significant increase in synaptic strength, as manifested by both an increase in IPSC amplitude and in success rate (Figures 4A and 4B) . In addition, we observed a small increase in IPSC half-width ( Figure 4C ; WT: 4.9 ± 0.1 ms, NL3 KO: 5.6 ± 0.2) but no change in the size of unitary minimal IPSCs ( Figure 4D ; WT: 25.3 ± 1.7 pA, NL3 KO: 29 ± 2.9 pA), or in the rate of finding synaptically connected pairs of neurons ( Figure 4E ; WT: 2 ± 0.2, NL3 KO: 1.8 ± 0.2). The fact that increased synaptic transmission at CCK basket cell synapses is equally observed in NL3 KO and R451C KI neurons shows that it is caused by a loss-of-function mechanism.
NL3 R451C KI Lowers the Probability of GABA Release at PV Basket Cell Synapses
The change in success rates in our paired recordings of synapses with the NL3 R451C KI or the NL3 KO mutations suggests a presynaptic origin for the observed phenotypes, despite the postsynaptic localization of NL3 (Budreck and Scheiffele, 2007) . To evaluate whether presynaptic changes alone (such as in the probability of release) could in principle account for the NL3 related phenotypes, we analyzed these phenotypes by modeling and computer simulations.
We first plotted bin-averaged PV basket cell IPSC amplitudes against their corresponding averaged success rates ( Figure 5A ; inset shows distribution of individual pairs). We then fitted these data with an equation that relates IPSC amplitudes to the success rate of transmission Figures S2A-S2C ) to estimate characteristic mean quantal size (Q) and number of release sites (N) for WT (n = 25) and R451C KI (n = 26) populations. The resulting estimates for Q were similar for both genotypes (mean and 95% confidence intervals: 21.9/12.5-31.3 pA and 17.5/16.4-18.6 pA for WT and R451C, respectively), as were the estimates for N (mean and 95% confidence intervals: 7.6/1.6-13.6 and 8.7/ 0-17.4 for WT and R451C synapses, respectively). These estimates support the notion that the synaptic phenotype in R451C mutant PV basket cell synapses was not due to a decrease in quantal size (see Figure 1D ) and, limited by the wide confidence interval of estimates, also suggest that the R451C phenotype was not due to a decrease in the number of release sites.
To examine the remaining possibility, namely that a lower neurotransmitter release probability (P R ) underlies the R451C phenotype, we performed computer simulations in which we modeled IPSCs at different P R values (Figures 5B and S3) . In this computational model, we incorporated a minimal set of synaptic parameters that allowed us to simulate the IPSC amplitudes and success rates, and to compare these parameters to the experimental data. The simulation parameters included, in addition to the number of release sites (N), the mean and the variance of the release probability (P R and s PR ) and the mean and the variance of the quantal amplitude (Q and s Q ). For each simulated paired recording, the computationally determined IPSC (cIPSC) was derived as cIPSC = P N i = 1 p i ,q i , and the computationally determined success rate (cSuccesses) was derived as cSuccess = ½1 À Q N i = 1 ð1 À p i Þ,100, where p i and q i are the probability of release and the quantal amplitude in the i-th release site, respectively (see Experimental Procedures and Figures S3A-S3G) .
We started the simulations by using Q and N values estimated from the population quantal analysis ( Figure 5A ; see above) to derive values for P R , s PR , and s Q that result in cIPSCs and cSuccesses which approximate the experimentally determined IPSCs and success rates. For PV basket cell IPSCs in WT neurons, we found that a P R = 0.23, together with a s PR = 0.224 and a s Q = 2.25 (Q = 21 pA and N = 7, per modeling), provided computationally determined cIPSCs and cSuccesses that did not significantly differ from the experimental data (mean difference ± SD for IPSCs: 0 ± 6 pA; for success rates: 0 ± 0.02; t test, p > 0.5 for both). For computer simulation of R451C synapses, we found that much lowered release probabilities, P R = 0.11, together with a s PR = 0.09 and a s Q = 1.65 (Q = 17 pA and N = 8, per modeling) were needed to replicate the experimental data (mean difference ± SD for IPSCs: 0 ± 0.99 pA; for success rates: 0 ± 0.01; t test, p > 0.5 for both). These simulations thus suggest that an $2-fold decrease in the probability of GABA release could sufficiently explain the NL3 R451C KI phenotype in PV basket cell synapses. These conclusions were further supported by consequent analysis of biocytin-filled axons ( Figure 5C ), which also did not indicate a difference in the number of synapses formed by individual PV basket cells (WT: 0.33 ± 0.03 and R451C: 0.26 ± 0.01, synapses per mm, Mann-Whitney RST, p = 0.152).
Next, we sought to determine a cause for lower release rates in PV basket cell synapses in the R451C KI mice. We reasoned that such decreases in release rate could be caused by NL3 mutation-driven alterations of the presynaptic release machinery, or alternatively, by overactivation of a presynaptic receptor, such as a neuropeptide receptor, that physiologically suppresses GABA release from these synapses (Freund and Katona, 2007) . We addressed this latter possibility by application of pharmacological agents in paired recording experiments.
Activation of two presynaptic G protein-coupled receptors, namely m-opioid and M2 muscarinic-receptors, is known to suppress GABA release at PV basket cell synapses (Glickfeld et al., 2008; Szabó et al., 2010 ). Thus, we tested the effect of the m-opioid receptor antagonist CTAP (500 nM; Figure 5D ; n = 4 pairs) and of the M2 muscarinic-receptor antagonist AF-DX (10 mM; Figure 5E ; n = 4 pairs) in paired-recordings of PV basket cell to pyramidal neuron synapses in NL3 R451C KI mice. Neither antagonist increased IPSC amplitudes in paired recordings, indicating that tonic activation of these receptors does not account for the decreased transmission at PV basket cell synapses in R451C KI mice. In additional control experiments, both antagonists reliably reversed the effect of their corresponding agonists, DAMGO (1 mM) and carbachol (5 mM; not shown). Thus, the presence of NL3 the R451C mutation likely induces a functional change in the presynaptic release properties of PV basket cell synapses.
Neuroligin-3 Is Essential for Tonic Endocannabinoid Signaling at CCK Basket Cell Synapses Our data suggest that a loss of NL3 function produces an increase in GABA release at synapses formed by CCK basket cells onto pyramidal neurons synapses. CCK basket cell synapses exhibit a distinct feature that offers an immediate hypothesis to account for the observed phenotype. This feature consists of the efficient suppression of GABA release from CCK basket cell terminals by the endocannabinoid-mediated activation of presynaptic CB1 receptors (reviewed in Alger, 2002; Piomelli, 2003; Freund and Katona, 2007) .
Endocannabinoids are secreted from postsynaptic pyramidal neurons to activate presynaptic CB1 receptors in two principal modes. Phasic secretion of endocannabinoids is induced by postsynaptic depolarization and/or mGluR5 activation and mediates decreases in synaptic transmission during short-and longterm plasticity. Tonic secretion of endocannabinoids affects synaptic transmission over longer time periods (reviewed in Alger, 2012; Katona and Freund, 2012) . A deficiency in tonic endocannabinoid signaling, with or without an effect on phasic endocannabinoid signaling, would be expected to enhance the probability of GABA release, and thus would increase IPSCs similar to what we observed in R451C KI and NL3 KO neurons. Thus, we tested the hypothesis that a loss of function of NL3-either via the KO or via the R451C KI-impairs tonic endocannabinoid signaling.
In wild-type synapses, bath application of 10 mM AM251 (a CB1 receptor antagonist and inverse agonist) caused an $100% increase in IPSC amplitudes and $50% increase in success rate (Figures 6A and 6B ; 1 Hz AP firing), reflecting disinhibition of GABA release by blocking tonically active CB1 receptors (Neu et al., 2007) . In NL3 KO synapses, strikingly, AM251 did not enhance IPSC amplitudes ( Figures 6A, S4A , and S4B) or success rates of synaptic transmission ( Figures 6B, S4A , and S4B). These findings suggest that IPSC amplitudes in the NL3 KO were larger because these synapses express higher release probabilities due to an apparent lack of tonic CB1 receptor activation.
To evaluate whether differences in the release probability alone, without other possible consequences of NL3 deletion, could explain the observed phenotype, we again used modeling and computer simulations. Fitting of the bin-averaged IPSCsuccesses data ( Figures 6C and S3A-S3C ) resulted in similar Q and N estimates for the NL3 WT and KO data sets (mean and 95% confidence intervals; Q: 39 / 30.8-47.3 and 46.2 / 14.1-78.4 pA, and N: 5.6 / 4.1-7 and 4.4 / À2.9-11.8, for WT and NL3 KO, respectively). Using these parameter estimates in subsequent simulations ( Figures 6D and S3A-S3G) , we found that the mean values of simulated IPSC-successes distributions were not significantly different from experimental values (inset in left panel) when P R = 0.12 (together with a s PR = 0.19 and a s Q = 2; Q = 39 pA and n = 6 per model estimates) for NL3 WT, 
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and when P R = 0.26 (together with a s PR = 0.26 and a s Q = 2.1; Q = 46.2 pA and n = 5 per model estimates) for NL3 KO. In addition, we quantified axonal bouton densities ( Figure 6E ), which were not different between the two genotypes (WT: 0.18 ± 0.01 and NL3 KO: 0.18 ± 0.01, per mm, t test, p = 0.779). Together, these analyses suggest that the loss of tonic CB1 receptor activation, and the consequent $2-fold increase in the probability of GABA release, is sufficient to account for the entire phenotype of the NL3 deletion at these synapses.
We next determined whether the loss of tonic CB1 receptor activation was affecting GABA release only from basket cell synapses, or whether all CB1-containing GABAergic synapses exhibit this phenotype. Thus, we repeated the CB1 receptor blocking experiments by monitoring IPSCs evoked by extracellular stimulation (which will cause GABA release from a broad set of presynaptic fibers that include CB1-receptor-containing axons). Application of AM251 again enhanced IPSCs in CA1 pyramidal cells, but consistently failed to do so in the NL3 KO ( Figure 6F ). We also repeated these latter extracellular stimulation experiments with CP 945,598, a CB1 receptor antagonist that is structurally unrelated to AM251. Bath application of CP 945,598 (5 mM) replicated the findings with AM251 ( Figure 6G ), independently confirming the absence of tonic EC signaling in NL3 KO mice.
Similar to the NL3 KO, paired recordings from slices prepared from the NL3 R451C KI mice revealed that the effect of AM251 on CCK basket cell IPSCs was greatly reduced (Figures 6H and 6I ). These data suggest that NL3 is essential for the tonic endocannabinoid signaling that inhibits GABA release from CCK basket cell synapses. Furthermore, we tested whether the NL3 KO may alter tonic CB1 receptor-mediated signaling at glutamatergic synapses. We stimulated Schaffer-collateral synapses and recorded from CA1 pyramidal cells (in the presence of 50 mM picrotoxin). However, bath application of AM251 (10 mM) failed to increase EPSC amplitudes in either WT slices or NL3 KO slices ( Figure 6J ; see also Hoffman et al., 2010) . Together, these data suggest that NL3-related mutations may impair tonic endocannabinoid signaling at CB1 receptor-containing inhibitory, but not excitatory synapses.
NL3 Is Not Required for Phasic Endocannabinoid Signaling
A loss of tonic endocannabinoid signaling could be due to a specific ablation of tonic endocannabinoid secretion or to a general block of all endocannabinoid secretion or endocannabinoid sensing, for example due to a removal of CB1 receptors.
To differentiate between these possibilities, we examined phasic endocannabinoid signaling in NL3 KO mice. We first analyzed depolarization-induced suppression of inhibition (DSI). During DSI, depolarization of pyramidal neurons induces transient release of endocannabinoids, which retrogradely activate CB1 receptors, leading to powerful blockade of GABA release that can last for several seconds (Pitler and Alger, 1994; Wilson and Nicoll, 2001; Fö ldy et al., 2006) . These experiments showed that the NL3 KO did not affect the magnitude or time course of DSI, documenting that CB1 receptors were properly localized and phasic endocannabinoid signaling was retained in NL3 KO mice ( Figure 7A ). We also tested whether the NL3 KO alters the phasic endocannabinoid signaling that induces a long-term depression of inhibitory synapses (I-LTD; Chevaleyre and Castillo, 2003; reviewed in Castillo et al., 2011) . High-frequency extracellular stimulation at the border of strata pyramidale and radiatum reliably induced I-LTD both in wild-type and in NL3 KO mice ( Figure 7B ). Thus, the NL3 KO does not block two different forms of synaptic plasticity dependent on phasic endocannabinoid signaling.
DISCUSSION
In the present study, we systematically compared the synaptic effects of two different mutations in NL3 that are associated with autism, and examined in paired recordings inhibitory synapses that are formed by two classes of presynaptic basket cells onto the same class of postsynaptic pyramidal neurons in the hippocampus.
This study had two goals. The first goal was based on the lack of a common phenotype produced by the two NL3 mutations in mice, despite their shared association with autism in humans, prompting us to search for such a common phenotype. As a starting point in this search, we used the altered rate of spontaneous mini activity that we had previously identified in NL3 KO mice (Etherton et al., 2011a) . We were led in this search by the notion that the lack of a similar phenotype in R451C mutant synapses could have been due to confounding gain-of-function effects of the R451C substitution on other subsets of synapses in the same neuron, which may have occluded a common phenotype shared by the R451C KI and NL3 KO neurons. Thus, to search for common phenotypes, we used paired recordings which enabled us to separately monitor defined synapses originating from two different classes of inhibitory basket cells in the hippocampus.
(E) Light microscopy analysis of the bouton density of CCK basket cell axons. Left: example of axonal segments for axons in WT and NL3 KO mice. Right: summary data from WT (n = 6) and NL3 KO (n = 7) mice. p = 0.779, t test. Mean ± SEM. The second goal of this study was stimulated by our earlier results demonstrating that the R451C substitution produced different synaptic phenotypes in distinct brain regions (Tabuchi et al., 2007; Etherton et al., 2011a) . These results led us to test whether the NL3 KO and the R451C KI mutations might produce different phenotypes even in distinct synapses formed onto the same postsynaptic neuron. The differences in NL3 phenotypes in different brain regions supported the hypothesis that NL3 does not simply act in establishing synapses as such, but functions to specify synaptic properties depending on the presynaptic partner, a hypothesis that would predict that synapses formed by different presynaptic partners on the same postsynaptic neuron may also exhibit distinct changes in NL3 mutants.
Our study addresses both goals. The results suggest three major conclusions that have implications not only for autism pathophysiology, but also for synapse formation and synaptic endocannabinoid signaling.
First, we unexpectedly found that NL3 is essential for tonic but not phasic endocannabinoid signaling. The mechanisms of tonic endocannabinoid signaling are not well studied-in fact, its very existence as a specific process was unclear (Kim and Alger, 2010; Alger, 2012) . Our finding that tonic endocannabinoid signaling is impaired in NL3 KO neurons (and R451C KI neurons) validates this form of endocannabinoid signaling as a specific regulatory process that is not an ''accident'' of endocannabinoid leakage or spillover and identifies NL3 as the only protein known to be specifically required for tonic endocannabinoid secretion. The loss of tonic endocannabinoid signaling is the likely cause for the change in mini event frequency we previously observed in NL3 KO mice (Etherton et al., 2011a) . The fact that this phenotype is caused by both the NL3 KO and the R451C KI suggests that a loss of tonic endocannabinoid signaling may be a component of autism pathogenesis and suggests new avenues for potential treatments (Cravatt and Lichtman, 2003; Piomelli, 2003; Katona and Freund, 2008) . Although the mechanism by which NL3 acts in tonic endocannabinoid secretion is unknown, it seems likely that NL3 serves to localize the as yet unknown tonic secretory machinery to synapses via trans-synaptic interactions with neurexins. Alternatively, it is conceivable that the NL3 loss of function activates an enzyme that selectively degrades ligands of tonic but not the phasic endocannabinoid signal (Alger and Kim, 2011; Alger, 2012) .
Second, the R451C mutation causes both gain-and loss-offunction effects (Figure 8 ). We previously demonstrated that the R451C KI causes gain-of-function effects when we compared the phenotype of the NL3 KO and R451C KI mutations in inhibitory synapses in the cortex and excitatory synapses in the hippocampus (Tabuchi et al., 2007; Etherton et al., 2011a) . In these synapses, the NL3 KO elicited no major phenotype while the NL3 R451C KI produced specific increases in synaptic transmission. However, R451C loss-of-function effects were not detected in earlier studies, although they are consistent with the fact that the R451C mutation destabilizes NL3 and reduces its levels by $90% (De Jaco et al., 2010; Tabuchi et al., 2007) . The present paper now shows that the R451C mutation does indeed also cause loss-of-function phenotypes, thereby reconciling the observation of both this mutation and a NL3 deletion in autism (Jamain et al., 2003; Sanders et al., 2011) . Third, the R451C mutation causes distinct effects on different types of synapses of the same postsynaptic neuron (Figure 8 ). The differences between phenotypes induced by the R451C KI suggests that NL3 acts in a context-dependent manner not only in a regional sense (i.e., it has a different phenotype in cortical versus hippocampal synapses), but also within a brain region. This observation argues against what might be called a ''mechanical'' view of synaptic cell adhesion whereby a molecule performs the same function in all contexts-instead, the observations on the R451C mutation reveal that NL3 can perform distinct functions, presumably depending on the ligands that are available in a given synapse, a result that is consistent with previous results obtained for neuroligin-2 (Gibson et al., 2009) . Moreover, the inhibition of PV-containing synapses by the R451C substitution represents the first time the R451C mutation was found to decrease synaptic strength as in previous studies it always increased synaptic strength (Tabuchi et al., 2007; Etherton et al., 2011a) . The powerful size of this effect is again consistent with a major regulatory function of neuroligins in synapses.
The multitude of the effects of the R451C mutation on neurotransmission (Figure 8 ) is surprising and supports the notion that neuroligins participate in a balanced array of diverse functions, possibly via interactions with multiple ligands. Specifically, the R451C mutation may act by shifting the activity of NL3 in a fluid interaction network composed of multiple competing trans-synaptic ligands. Our previous studies suggested that at least neuroligin-1 functions as a trans-synaptic cell-adhesion molecule by binding both to neurexins and to as yet unidentified other ligands (Ko et al., 2009) . It is possible that the R451C mutation blocks the binding of NL3 to one of the ligands, and/or activates the binding of another ligand, thereby shifting the interaction network.
Although we show here that NL3 is selectively essential for tonic endocannabinoid signaling, this result does not exclude the possibility that NL3 performs other functions. In fact, analogous to other genes such as RIMs (Kaeser et al., 2012) , NL3 could perform additional major functions that are redundantly also performed by other neuroligins. The previous analysis of constitutive neuroligin triple KO mice strongly supports this notion by revealing functional redundancy among neuroligins (Varoqueaux et al., 2006) , as does the observation of multiple strong phenotypes produced by the R451C and R704C KI mutations in NL3 (Tabuchi et al., 2007; Etherton et al., 2011a Etherton et al., , 2011b . The requirement for NL3 in tonic endocannabinoid signaling affirms the notion that neuroligins specify synapse properties, as NL3 confers onto CCK-containing synapses tonic endocannabinoid signaling without influencing phasic signaling or other synaptic parameters. Tonic endocannabinoid signaling was not previously associated with a specific regulatory mechanism but the link to NL3 revealed here validates the importance of this signaling pathway and suggests a possible endocannabinoid involvement in autism.
EXPERIMENTAL PROCEDURES
Mouse Breeding and Genotyping Mice were genotyped as described previously (Tabuchi et al., 2007; Etherton et al., 2011a) . All animal protocols and husbandry practices were approved by the Institutional Animal Care and Use Committee at Stanford University.
Electrophysiology
Hippocampal slices (300 mm) were prepared from 3-4 weeks old NL3 R451C KI and NL3 KO mice. Slices were incubated at 33 C in sucrose-containing artificial cerebrospinal fluid (ACSF; 85 mM NaCl, 75 mM sucrose, 2.5 mM KCl, 25 mM glucose, 1.25 mM NaH 2 PO 4 , 4 mM MgCl 2 , 0.5 mM CaCl 2 and 24 mM NaHCO 3 ) for an hour and then incubated in the same solution at room temperature until recording. Electrophysiological recordings were made in ACSF containing 126 mM NaCl, 2.5 mM KCl, 10 mM glucose, 1.25 mM NaH 2 PO 4 , 2 mM MgCl 2 , 2 mM CaCl 2 , and 26 mM NaHCO 3 . Slices were visualized in an upright microscope (Olympus, BX-61WI) with infrared differential interference contrast optics. Whole-cell recordings were obtained from the interneurons with patch pipettes (King Precision Glass, Inc., 3-5 MU) filled with internal solution containing 126 mM K-gluconate, 4 mM KCl, 10 mM HEPES, 4 mM Mg-ATP, 0.3 Na-GTP, 10 mM phosphocreatine, and 0.2% biocytin (pH 7.2, 270-290 mOsm), and from postsynaptic pyramidal cells containing 40 mM CsCl, 90 mM K-gluconate, 1.8 mM NaCl, 1.7 mM MgCl 2 , 3.5 mM KCl, 0.05 mM EGTA, 10 mM HEPES, 2 mM Mg-ATP, 0.4 mM Na-GTP, 10 mM phosphocreatine (pH 7.2, 270-290 mOsm; in some of the recordings 0.2% biocytin was also added to this solution). All electrophysiological recordings were made at 33 C, using MultiClamp700B amplifiers (Molecular Devices, Sunnyvale, CA). Signals were filtered at 4 kHz using Bessel filter and digitized at 10 kHz with a Digidata 1440A analog-digital interface (Molecular Devices). Series resistance was monitored, and recordings were discarded if the series resistance changed significantly or reached 25 MU. The recorded traces were analyzed using Clampfit software (Molecular Devices). PV and CCK interneurons were distinguished based on their distinct electrophysiological spiking properties (Fö ldy et al., 2010) and by the presence of DSI in CCK basket cell synapses (see Figure 7A ). IPSCs were individually inspected and included in the analysis based on their onset latency following the presynaptic action potential. For statistical analysis Student's t test, paired t test or Mann-Whitney rank-sum test (RST) was used, and data are presented as mean ± SEM, unless noted otherwise; significance was p < 0.05.
Quantal Model
Individual basket cells innervate postsynaptic pyramidal cells via multiple release sites (N; Biró et al., 2006; Fö ldy et al., 2010) , in which intrinsically variable synaptic parameters (such as quantal size and release probability; Q and P R respectively) produce a trial-to-trial fluctuation in the IPSC amplitudes. The distribution of these fluctuations can be described by models that are based on binomial statistics and allow estimates of Q and N (Silver, 2003; Biró et al., 2006) . In this study, we ought to extend quantal modeling to analyze pooled data from multiple paired-recording experiments of defined synapse populations, and extract mean quantal information that is characteristic to each population. For modeling, we analyzed synapses by quantifying IPSC amplitudes and success rates. Assuming that each synapse population can be described by characteristic mean N and Q values, it is reasonable to assume that the pair-to-pair variability in IPSC amplitudes and success rates is dominated by variability in P R . In this case, the distribution of IPSC amplitudes and success rates should follow the IPSC = Q,N,ð1 À ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi 1 À Successes N p Þ model (see Figure S2 for more information). For fitting the IPSC model on experimental data, to estimate quantal parameters, we employed the builtin, unconstrained NonlinearModelFit algorithm in Mathematica 8 (Wolfram Research, Inc., Champaign, IL) . Note that the basic assumptions of this approach (i.e., the existence of characteristic Q and N values in each synapse population) were supported by the similarity between the observed and predicted IPSC distributions (see Figures 5A and 6C ).
Computational Model
In order to gain further qualitative insight into how pre-and postsynaptic changes may contribute to the synaptic phenotypes produced by NL3 mutations, we devised a simple computational model that incorporated five modifiable synaptic parameters: the number of release sites (N) and the mean and variance of the release probability (P R and s PR , respectively) and of quantal IPSCs (Q and s Q , respectively). Note that nonzero variances were necessary to simulate variability both in the number of successful transmissions (by s PR ) and IPSC amplitudes (by s Q ). To initialize the simulations, p i values (that is the release probability of the i-th release site) were assigned randomly from a normal probability distribution function with P R mean and s PR variance for each release site. In addition, for each release site, q i values (that is the quantal size in the i-th release site) were randomly assigned from a log-normal probability distribution function of mean Q and s Q variance parameters (see Figure S3 for more information). Computational IPSCs (cIPSCs) and successes (cSuccesses) were derived as described in the text. For each condition, estimates of Q and N were adopted from the quantal model ( Figures 5A  and 6C ). Each simulation had the same sample size as the original data, and each simulation was repeated 50 times with random assignments of new p i and q i values. For statistical comparisons, we tested the null hypothesis that the difference between the mean computed and experimental successes and IPSCs were zero; simulation parameters were accepted when p > 0.05 using Student's t test. To estimate the robustness of the resulting simulation parameters, we quantified an average range for each parameter which still justifies the null-hypothesis: DP R = ± 0.006, Ds PR = ± 0.09, DQ = ± 0.7 pA and Ds Q = ± 0.06 pA (relative to values presented in the main text). Parameter deviations beyond these ranges independently resulted in statistically significant differences (p ( 0.05) between the simulated and experimental distributions. Simulations were implemented and run using Mathematica 8 (Wolfram Research, Inc.).
Neuroanatomy
After recordings, all slices were transferred into a fixative solution containing 4% paraformaldehyde and 0.2% picric acid in 0.1 M phosphate buffer. In order to examine the axonal and dendritic arbor of presynaptic basket cell, biocytinfilled cells were visualized after recordings with 3,3-diaminobenzidinetetrahydrochloride (0.015%) using PK-6100 DAB and Vectastain SK-4100 ABC kit (Vector Laboratories, Burlingame, CA). Example basket cells in Figures 1 and 2 were reconstructed using Neurolucida 10 (MBF Bioscience). For axonal bouton density quantification, axonal segments with corresponding boutons were reconstructed using Neurolucida 10. The length of the axons (which averaged 1180.4 ± 128.4 mm, mean length ± SEM, in the reconstructed cells) and bouton numbers were determined using NeuroExplorer (MBF Bioscience).
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